NEPH vs PG · P/E 48, rev $14.2M vs P/E 25, rev $84.28B
Nephros Inc (NEPH) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Nephros Inc (NEPH) is a medical instruments & supplies company listed on US.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported NEPH revenue for 2024-12-31 was $14.2M. Net income was $74.0K. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. NEPH currently screens at market cap $40.9M and trailing P/E 48.3.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
NEPH currently screens at market cap $40.9M and trailing P/E 48.3. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the NEPH and PG stock pages for the full models.
Not investment advice.